BioTheryX Revenue and Competitors

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • BioTheryX's estimated annual revenue is currently $3.3M per year.(i)
  • BioTheryX's estimated revenue per employee is $81,600

Employee Data

  • BioTheryX has 41 Employees.(i)
  • BioTheryX grew their employee count by -24% last year.

BioTheryX's People

NameTitleEmail/Phone
1
DirectorReveal Email/Phone
2
Senior Director Medicinal ChemistryReveal Email/Phone
3
Executive Director, CMCReveal Email/Phone
4
Founder/Senior AdvisorReveal Email/Phone
5
Scientist IReveal Email/Phone
6
Senior ScientistReveal Email/Phone
7
Principal ScientistReveal Email/Phone
8
Scientist IIReveal Email/Phone
9
Senior ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$24M21410%N/AN/A
#2
$4.8M52-4%N/AN/A
#3
$2.9M369%N/AN/A
#4
$22.4M2005%N/AN/A
#5
$1.7M249%N/AN/A
#6
$10.1M99-1%N/AN/A
#7
$5.8M639%N/AN/A
#8
$3.2M39N/AN/AN/A
#9
$5.8M63-3%N/AN/A
#10
$0.8M13N/AN/AN/A
Add Company

What Is BioTheryX?

BioTheryX is a clinical-stage biopharmaceutical company focused on restoring protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition to develop treatments intended to extend and improve the quality-of-life of patients with life-threatening diseases. Our principal technology platform centers on targeted protein degradation, as well as PHM® ‘molecular glues', that enable the design of small molecules to regulate protein equilibrium. This technology is designed to utilize the body's own protein disposal system to selectively degrade and remove disease-causing proteins. It has potential applicability to a broad range of diseases, including targets that have to date been considered ‘undruggable'.

keywords:N/A

N/A

Total Funding

41

Number of Employees

$3.3M

Revenue (est)

-24%

Employee Growth %

N/A

Valuation

N/A

Accelerator

BioTheryX News

2022-04-17 - Biotheryx Announces Appointment of Jeff Caravella as Chief ...

Biotheryx is a clinical stage biopharmaceutical company discovering and developing a portfolio of innovative small molecule targeted protein...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.1M41-18%N/A
#2
$4.8M418%N/A
#3
$7.5M41-13%$269.2M
#4
$3.2M41-35%$39.4M
#5
$8.9M413%N/A